Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Declines By 16.7%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 500 shares, a decline of 16.7% from the November 15th total of 600 shares. Based on an average daily volume of 600 shares, the days-to-cover ratio is currently 0.8 days.

Mosaic ImmunoEngineering Price Performance

Shares of OTCMKTS CPMV remained flat at $1.00 during trading hours on Monday. 407 shares of the company traded hands, compared to its average volume of 897. Mosaic ImmunoEngineering has a fifty-two week low of $0.10 and a fifty-two week high of $1.13. The business’s 50 day moving average is $0.92 and its 200 day moving average is $0.81. The stock has a market cap of $7.24 million, a price-to-earnings ratio of -6.67 and a beta of 0.15.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.